Cardinal Health (CAH) FY2018 results: revenue $136.8 billion, up 5.3% on the year
Cardinal Health Inc. (CAH) reported revenue of $136.8 billion for fiscal 2018, the year ended 30 June 2018, up 5.3% on the year before. Net income was $256 million, down 80.1%, and diluted earnings per share $0.81. The figures are the company's own, from the 10-K it filed with the SEC on 22 August 2018.
Revenue
$136.8 billion
+5.3% on the year
FY2011FY2018
Operating margin
0.1%
1.6% a year earlier
FY2011FY2018
Net income
$256 million
-80.1% on the year
FY2011FY2018
Diluted EPS
$0.81
-79.9% on the year
FY2011FY2018
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Revenue
136,809
129,976
121,546
+5.3%
Cost of revenue
129,628
123,432
115,003
+5.0%
Gross profit
7,181
6,544
6,543
+9.7%
Gross margin
5.2%
5.0%
5.4%
Selling, general and administrative
4,596
3,775
3,648
+21.7%
Operating income
126
2,120
2,459
-94.1%
Operating margin
0.1%
1.6%
2.0%
Interest expense
329
201
178
+63.7%
Pre-tax income
-228
1,924
2,276
Income tax
-487
630
845
Effective tax rate
n/a
32.7%
37.1%
Net income
256
1,288
1,427
-80.1%
Net margin
0.2%
1.0%
1.2%
Diluted EPS
$0.81
$4.03
$4.32
-79.9%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Operating cash flow
2,768
1,184
2,971
+133.8%
Capital expenditure
384
387
465
-0.8%
Free cash flow
2,384
797
2,506
+199.1%
Free cash flow margin
1.7%
0.6%
2.1%
Cash from investing
-5,608
-405
-4,080
Cash from financing
-2,276
3,746
-1,139
Depreciation and amortisation
1,032
717
641
+43.9%
Share-based compensation
85.0
96.0
111
-11.5%
Buybacks
550
600
651
-8.3%
Dividends paid
581
577
512
+0.7%
Dividend per share
$1.85
$1.80
$1.55
+2.8%
Diluted shares, weighted
315m
320m
330m
-1.6%
Balance sheet
$ million
FY2018
FY2017
FY2016
On the year
Last 8 years
Shareholders' equity
6,059
6,808
6,554
-11.0%
Non-controlling interest
0.0
20.0
17.0
Redeemable equity
12.0
118
117
-89.8%
Debt
9,013
10,395
5,539
-13.3%
Other liabilities
24,867
22,771
21,895
+9.2%
Total liabilities and equity
39,951
40,112
34,122
-0.4%
Fixed assets
2,487
1,879
1,796
+32.4%
Goodwill
8,316
7,221
7,167
+15.2%
Intangible assets
3,913
1,986
2,259
+97.0%
Investments
n/a
65.0
200
Cash and equivalents
1,763
6,879
2,356
-74.4%
Receivables
7,800
8,048
7,405
-3.1%
Inventory
12,308
11,301
10,615
+8.9%
Other assets
3,364
2,733
2,324
+23.1%
Total assets
39,951
40,112
34,122
-0.4%
10-K for the year ended 30 June 2018, filed 22 August 2018: the filing.